Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;30(6):2197-2209.
doi: 10.1007/s10787-022-01045-4. Epub 2022 Aug 10.

Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1/M2 polarization and inhibition of NLRP3 inflammasome activation

Affiliations

Nebivolol elicits a neuroprotective effect in the cuprizone model of multiple sclerosis in mice: emphasis on M1/M2 polarization and inhibition of NLRP3 inflammasome activation

Antoinette G Naeem et al. Inflammopharmacology. 2022 Dec.

Abstract

Background and aim: Multiple sclerosis (MS) is a demyelinating neurodegenerative inflammatory disease affecting mainly young adults. Microgliosis-derived neuroinflammation represents a key hallmark in MS pathology and progression. Nebivolol (Neb) demonstrated antioxidant, anti-inflammatory and neuroprotective properties in several brain pathologies. This study was conducted to investigate the potential neuroprotective effect of Neb in the cuprizone (Cup) model of MS.

Methods: C57Bl/6 mice were fed 0.2% Cup mixed into rodent chow for 5 weeks. Neb (5 and 10 mg/kg/day) was administered by oral gavage during the last 2 weeks.

Results: Neb prevented Cup-induced weight loss and motor deficits as evidenced by increased latency to fall in the rotarod test and enhanced locomotor activity as compared to Cup-intoxicated mice. Neb reversed Cup-induced demyelination as confirmed by Luxol fast blue staining and myelin basic protein western blotting. Administration of Neb modulated microglial activation status by suppressing M1 markers (Iba-1, CD86, iNOS, NO and TNF-α) and increasing M2 markers (Arg-1 and IL-10) as compared to Cup-fed mice. Furthermore, Neb hindered NLRP3/caspase-1/IL-18 inflammatory cascade and alleviated oxidative stress by reducing lipid peroxidation, as well as increasing catalase and superoxide dismutase activities.

Conclusion: These findings suggest the potential neuroprotective effect of Neb in the Cup-induced model of MS in mice, at least partially by virtue of shifting microglia towards M2 phenotype, mitigation of NLRP3 inflammasome activation and alleviation of oxidative stress.

Keywords: Cuprizone; M1/M2 polarization; Multiple sclerosis; NLRP3; Nebivolol.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Study timeline showing Cup and Neb dosing regimens
Fig. 2
Fig. 2
The effect of Neb on Cup-induced motor abnormalities. a Locomotor activity test. b Rotarod test. Data are presented as means ± SD (n = 6). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 3
Fig. 3
The effect of Neb on Cup-induced body weight changes. a, b:Statistically significant from the control and Cup-treated groups, respectively, at P < 0.05. Statistical analysis was performed using two-way ANOVA followed by Bonferroni test for multiple comparisons between groups
Fig. 4
Fig. 4
a Representative photomicrograph of LFB stained CC sections (Control group) showing normal positive staining intensity (arrow). b Cup group showing a significant decrease in staining intensity (star). c, d Cup + Neb (5 and 10 mg/kg), respectively, both showing elevated staining intensity as compared to Cup-intoxicated mice (arrow). e Neb (10 mg/kg) showing positive staining intensity (arrow). Magnification 400× . f Percentage of myelinated neurofibers resulting from LFB expressed as a percentage of control. Data are presented as means ± SD (n = 6). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 5
Fig. 5
a Western blot analysis of brain MBP. b Densitometric quantitation of MBP protein expression. Data are presented as means ± S.D. (n = 3). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey's test for multiple comparisons between groups
Fig. 6
Fig. 6
a Western blot analysis of brain Iba-1, CD86 and iNOS. b, c and d Densitometric quantitation of Iba-1, CD86 and iNOS protein expression, respectively. Data are presented as means ± SD. (n = 3). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 7
Fig. 7
The effect of Neb on TNF-α (a) and nitrite (b) levels in the brain tissues of Cup-treated mice. Data are presented as means ± SD (n = 6). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 8
Fig. 8
a Western blot analysis of brain Arg-1. b Densitometric quantitation of Arg-1 protein expression. Data are presented as means ± S.D. (n = 3). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 9
Fig. 9
The effect of Neb on IL-10 levels in the brain tissues of Cup-treated mice. Data are presented as means ± SD (n = 6). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey's test for multiple comparisons between groups
Fig. 10
Fig. 10
a Western blot analysis of brain NLRP3 and cleaved caspase-1. b Densitometric quantitation of NLRP3 protein expression. c Densitometric quantitation of cleaved caspase-1 protein expression. Data are presented as means ± SD. (n = 3). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 11
Fig. 11
The effect of Neb on IL-18 levels in the brain tissues of Cup-treated mice. Data are presented as means ± SD (n = 6). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups
Fig. 12
Fig. 12
The effect of Neb on oxidative stress markers: MDA levels a, catalase b and SOD c activities in the brain tissues of Cup-intoxicated mice. Data are presented as means ± SD (n = 6). a, b, c: Statistically significant from the control, Cup and Cup + Neb (5 mg/kg)-treated groups, respectively, at P < 0.05. Statistical analysis was performed using one-way ANOVA followed by Tukey’s test for multiple comparisons between groups

Similar articles

Cited by

References

    1. Abd El Aziz AE, Sayed RH, Sallam NA, El Sayed NS. Neuroprotective effects of telmisartan and nifedipine against cuprizone-induced demyelination and behavioral dysfunction in mice: roles of NF-κB and Nrf2. Inflammation. 2021 doi: 10.1007/s10753-021-01447-6. - DOI - PubMed
    1. Abdelkader NF, Saad MA, Abdelsalam RM. Neuroprotective effect of nebivolol against cisplatin-associated depressive-like behavior in rats. J Neurochem. 2017 doi: 10.1111/jnc.13978. - DOI - PubMed
    1. Abdel-Maged AES, Gad AM, Rashed LA, et al. Repurposing of secukinumab as neuroprotective in cuprizone-induced multiple sclerosis experimental model via inhibition of oxidative, inflammatory, and neurodegenerative signaling. Mol Neurobiol. 2020 doi: 10.1007/s12035-020-01972-9. - DOI - PubMed
    1. Aryanpour R, Pasbakhsh P, Zibara K, et al. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Int Immunopharmacol. 2017 doi: 10.1016/j.intimp.2017.08.007. - DOI - PubMed
    1. Bakker DA, Ludwin SK. Blood-brain barrier permeability during cuprizone-induced demyelination Implications for the pathogenesis of immune-mediated demyelinating diseases. J Neurol Sci. 1987 doi: 10.1016/0022-510X(87)90055-4. - DOI - PubMed

MeSH terms